XML 16 R4.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenues:        
Total revenues $ 257,606 $ 999,571 $ 2,254,601 $ 2,754,401
Operating expenses:        
Research and development 2,044,980 3,591,897 7,799,472 9,786,138
General and administrative 1,412,672 3,234,133 6,098,716 9,720,598
Total operating expenses 3,457,652 6,826,030 13,898,188 19,506,736
Loss from operations (3,200,046) (5,826,459) (11,643,587) (16,752,335)
Other income (expenses):        
Arbitration settlement       (118,880)
Interest income 218,085 99,750 337,819 138,653
Loss from continuing operations (2,981,961) (5,726,709) (11,305,768) (16,732,562)
Discontinued operations:        
Loss from discontinued operations, net of tax   (1,192,874) (2,922,406) (9,341,717)
Gain on disposal of discontinued operations     8,794,426  
Income (loss) from discontinued operations   (1,192,874) 5,872,020 (9,341,717)
Net loss $ (2,981,961) $ (6,919,583) $ (5,433,748) $ (26,074,279)
Net earnings (loss) per share:        
Loss from continuing operations, basic $ (0.34) $ (0.69) $ (1.29) $ (2.01)
Income (loss) from discontinued operations, basic   (0.14) 0.67 (1.12)
Net loss per share, basic (0.34) (0.83) (0.62) (3.13)
Loss from continuing operations, diluted (0.34) (0.69) (1.29) (2.01)
Income (loss) from discontinued operations, diluted   (0.14) 0.66 (1.12)
Net loss per share, diluted $ (0.34) $ (0.83) $ (0.62) $ (3.13)
Weighted average number of common shares outstanding, basic 8,825,881 8,359,920 8,782,340 8,343,477
Weighted average number of common shares outstanding, diluted 8,825,881 8,359,920 8,834,512 8,343,477
Grant income        
Revenues:        
Total revenues $ 257,606 $ 999,571 $ 2,254,601 $ 2,754,401